BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2847086)

  • 1. Differential effects of competitive and non-competitive N-methyl-D-aspartate antagonists on glucose use in the limbic system.
    Nehls DG; Kurumaji A; Park CK; McCulloch J
    Neurosci Lett; 1988 Aug; 91(2):204-10. PubMed ID: 2847086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of NMDA antagonists, MK-801 and CPP, upon local cerebral glucose use.
    Kurumaji A; Nehls DG; Park CK; McCulloch J
    Brain Res; 1989 Sep; 496(1-2):268-84. PubMed ID: 2553203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of MK-801 upon local cerebral glucose utilisation in conscious rats and in rats anaesthetised with halothane.
    Kurumaji A; McCulloch J
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):786-94. PubMed ID: 2684992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of unilateral intrahippocampal injection of MK-801 upon local cerebral glucose utilisation in conscious rats.
    Kurumaji A; McCulloch J
    Brain Res; 1990 Jun; 518(1-2):342-6. PubMed ID: 2202490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of MK-801 upon local cerebral glucose utilisation in conscious rats following unilateral lesion of caudal entorhinal cortex.
    Kurumaji A; McCulloch J
    Brain Res; 1990 Oct; 531(1-2):72-82. PubMed ID: 2289138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentobarbital-like discriminative stimulus effects of N-methyl-D-aspartate antagonists.
    Willetts J; Balster RL
    J Pharmacol Exp Ther; 1989 May; 249(2):438-43. PubMed ID: 2542531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of N-methyl-D-aspartate receptor blockade with MK-801 upon the relationship between cerebral blood flow and glucose utilisation.
    Nehls DG; Park CK; MacCormack AG; McCulloch J
    Brain Res; 1990 Mar; 511(2):271-9. PubMed ID: 2159360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of competitive and noncompetitive N-methyl-D-aspartate (NMDA) antagonists in rats trained to discriminate NMDA from saline.
    Willetts J; Balster RL
    J Pharmacol Exp Ther; 1989 Nov; 251(2):627-33. PubMed ID: 2553930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsant effects of antagonists of the N-methyl-D-aspartate receptor complex in a genetic model of epilepsy: the quaking mouse.
    Mitrovic N; Besson MJ; Maurin Y
    Eur J Pharmacol; 1990 Feb; 176(3):357-61. PubMed ID: 2158455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-CPP-ene (SDZ EAA 494), a potent and competitive N-methyl-D-aspartate (NMDA) antagonist: effect on spontaneous activity and NMDA-induced depolarizations in the rat neocortical slice preparation, compared with other CPP derivatives and MK-801.
    Lowe DA; Neijt HC; Aebischer B
    Neurosci Lett; 1990 Jun; 113(3):315-21. PubMed ID: 2166255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the NMDA receptor/channel antagonists CPP and MK801 on hippocampal field potentials and long-term potentiation in anesthetized rats.
    Abraham WC; Mason SE
    Brain Res; 1988 Oct; 462(1):40-6. PubMed ID: 2846123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the anticonvulsant effects of competitive and non-competitive antagonists of the N-methyl-D-aspartate receptor.
    Nevins ME; Arnolde SM
    Brain Res; 1989 Nov; 503(1):1-4. PubMed ID: 2558775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.
    Tricklebank MD; Singh L; Oles RJ; Preston C; Iversen SD
    Eur J Pharmacol; 1989 Aug; 167(1):127-35. PubMed ID: 2550253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of febrile seizures in epileptic chicks by N-methyl-D-aspartate receptor antagonists.
    Pedder SC; Wilcox RI; Tuchek JM; Johnson DD; Crawford RD
    Can J Physiol Pharmacol; 1990 Jan; 68(1):84-8. PubMed ID: 2158387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic administration of MK-801 upon local cerebral glucose utilisation and ligand binding to the NMDA receptor complex.
    Kurumaji A; Ikeda M; Dewar D; McCormack AG; McCulloch J
    Brain Res; 1991 Nov; 563(1-2):57-65. PubMed ID: 1838495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection by NMDA antagonists against selective cell loss following transient ischaemia.
    Swan JH; Meldrum BS
    J Cereb Blood Flow Metab; 1990 May; 10(3):343-51. PubMed ID: 2158499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Labeling of NMDA receptor channels by [3H]MK-801 in brain synaptic membranes treated with Triton X-100.
    Yoneda Y; Ogita K
    Brain Res; 1989 Oct; 499(2):305-14. PubMed ID: 2572302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competitive (AP7) and non-competitive (MK-801) NMDA receptor antagonists differentially alter glucose utilization in rat cortex.
    Clow DW; Lee SJ; Hammer RP
    Synapse; 1991 Apr; 7(4):260-8. PubMed ID: 1828310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracerebroventricular application of competitive and non-competitive NMDA antagonists induce similar effects upon rat hippocampal electroencephalogram and local cerebral glucose utilization.
    Boddeke HW; Wiederhold KH; Palacios JM
    Brain Res; 1992 Jul; 585(1-2):177-83. PubMed ID: 1511299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excitatory amino acid neurotoxicity at the N-methyl-D-aspartate receptor in cultured neurons: pharmacological characterization.
    Lysko PG; Cox JA; Vigano MA; Henneberry RC
    Brain Res; 1989 Oct; 499(2):258-66. PubMed ID: 2572298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.